ANGELA MINIUM: Open Payments
NPI 1083267363 · LOS ALAMOS, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$412 in 21 payments from 10 companies in 2025. Trend: 2023 $612 · 2024 $548 · 2025 $412
Food & beverage: $412
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $107 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| RECORDATI_RARE_DISEASES_INC. | 2 | $48 |
| PFIZER INC. | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| Novo Nordisk Inc | 2 | $35 |
| SANOFI PASTEUR INC. | 1 | $29 |
| Dexcom, Inc. | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
Products named: MOUNJARO, BREZTRI, JARDIANCE, ISTURISA, Ozempic, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, Dexcom G6 Transmitter, PAXLOVID.
Industry payments across NM — which companies pay providers there.
